Trial Profile
Use of h-R3 MaB and radiotherapy in treatment of pediatric patients with intrinsic diffuse astrocytomas of brain stem
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Astrocytoma
- Focus Therapeutic Use
- 29 Aug 2011 New trial record